FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称REMIBRUTINIB
异名/同义词BENZAMIDE, N-(3-(6-AMINO-5-(2-(METHYL(1-OXO-2-PROPEN-1-YL)AMINO)ETHOXY)-4-PYRIMIDINYL)-5-FLUORO-2-METHYLPHENYL)-4-CYCLOPROPYL-2-FLUORO-
LOU064-NXA
N-(3-(6-AMINO-5-(2-(N-METHYLACRYLAMIDO)ETHOXY)PYRIMIDIN-4-YL)-5-FLUORO-2-METHYLPHENYL)-4-CYCLOPROPYL-2-FLUOROBENZAMIDE
NVP-LOU064-NXA
REMIBRUTINIB
REMIBRUTINIB [INN]
REMIBRUTINIB [USAN]
REMIBRUTINIB [WHO-DD]
CAS登记号1787294-07-8
物质唯一标识(Unique Ingredient Identifier)I7MVZ8HDNU
分子式C27H27F2N5O3
国际化合物标识(International Chemical Identifier,InChI)CUABMPOJOBCXJI-UHFFFAOYSA-N
SMILESO(CCN(C(C=C)=O)C)c1c(ncnc1N)-c2c(C)c(NC(=O)c3c(F)cc(cc3)C4CC4)cc(c2)F
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System